Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Cancer Statistics, 2010

2010 • 12,557 citations

Cell Signaling by Receptor Tyrosine Kinases

2010 • 7,477 citations

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

2006 • 4,800 citations

Cell Signaling by Receptor Tyrosine Kinases

2000 • 3,570 citations

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

2000 • 2,694 citations

EGFR and cancer prognosis

2001 • 2,068 citations

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

2004 • 1,709 citations

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1997 • 1,599 citations

The EGF receptor family as targets for cancer therapy

2000 • 1,339 citations

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

2005 • 1,081 citations

Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor

2002 • 972 citations

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

2007 • 937 citations

Single-molecule imaging of EGFR signalling on the surface of living cells

2000 • 884 citations

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

1997 • 841 citations

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

1983 • 792 citations

Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin

2000 • 748 citations

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

2008 • 735 citations

KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

2007 • 597 citations

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

2005 • 528 citations

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

2000 • 498 citations

Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer

2001 • 479 citations

Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.

1983 • 456 citations

Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies

1993 • 422 citations

Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy

2000 • 394 citations

ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases

1999 • 365 citations

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.

2002 • 351 citations

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia

2002 • 306 citations

Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.

2001 • 299 citations

Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.

1994 • 281 citations

Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy

2008 • 279 citations

Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.

1993 • 245 citations

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

1999 • 245 citations

Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.

1996 • 228 citations

The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis

1999 • 190 citations

Epidermal Growth Factor Receptor Family and Chemosensitization

1997 • 176 citations

Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

1996 • 141 citations

Nuclear targeting of Bax during apoptosis in human colorectal cancer cells

1998 • 138 citations

Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer

2009 • 108 citations

Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix

2004 • 108 citations

Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix

2000 • 92 citations

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer

2005 • 88 citations

Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease

2007 • 88 citations

Targeting the epidermal growth factor receptor: a clinical reality.

2001 • 84 citations

Epidermal growth factor receptor-targeted therapy in colorectal cancer

2002 • 75 citations

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma

2007 • 66 citations

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status

2005 • 65 citations

New therapeutic agents targeting the epidermal growth factor receptor.

2000 • 63 citations

Epidermal growth factor receptor-targeted therapy in colorectal cancer

2002 • 57 citations

A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials

2012 • 39 citations

Absence of epidermal growth factor receptor mutations in cervical cancer

2007 • 36 citations

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10

2002 • 30 citations

Biological Predictors of Response to Radiotherapy in Head and Neck Cancer: Recent Advances and Emerging Perspectives

2001 • 27 citations

Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression

2004 • 24 citations

Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma

2003 • 22 citations

Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients

1995 • 20 citations

“Low-risk” and “High-risk” HPV-infection and K-ras Gene Point Mutations in Human Cervical Cancer

2001 • 15 citations

Cisplatin plus Cetuximab in the Treatment of Recurrent and Persistent Cancers of the Cervix

2010 • 1 citations